Publikationen (41) Publikationen von MARÍA ESPERANZA HERREROS AVILÉS

2021

  1. A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides

    British Journal of Pharmacology, Vol. 178, Núm. 2, pp. 363-377

  2. Barcoded Asaia bacteria enable mosquito in vivo screens and identify novel systemic insecticides and inhibitors of malaria transmission

    PLoS Biology, Vol. 19, Núm. 12

  3. The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening

    Journal of Medicinal Chemistry, Vol. 63, Núm. 2, pp. 591-600

2018

  1. A high throughput screen for next-generation leads targeting malaria parasite transmission

    Nature Communications, Vol. 9, Núm. 1

  2. Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria" (Antimicrobial Agents and Chemotherapy (2018) 62:9 (e00012-18) DOI: 10.1128/AAC.00012-18)

    Antimicrobial Agents and Chemotherapy

  3. Gametocytes from K13 propeller mutant plasmodium falciparum clinical isolates demonstrate reduced susceptibility to dihydroartemisinin in the male gamete exflagellation inhibition assay

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 12

  4. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 5, pp. 1279-1290

  5. Synthesis and Structure-Activity Relationships of the Novel Antimalarials 5-Pyridinyl-4(1 H)-Pyridones

    Journal of Medicinal Chemistry, Vol. 61, Núm. 8, pp. 3422-3435

  6. Uct943, a next-generation plasmodium falciparum pi4k inhibitor preclinical candidate for the treatment of malaria

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 9

2017

  1. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance

    Nature Communications, Vol. 8

  2. Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen

    Nature Communications, Vol. 8

2016

  1. A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents

    Malaria Journal, Vol. 15, Núm. 1

  2. Transmission-blocking potential of MEFAS, a hybrid compound derived from artesunate and mefloquine

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 5, pp. 3145-3147

2015

  1. A new Set of chemical starting points with Plasmodium falciparum transmission-blocking potential for antimalarial drug discovery

    PLoS ONE, Vol. 10, Núm. 8

  2. Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 6, pp. 3298-3305

2013

  1. Erratum: Potent antimalarial 4-pyridones with improved physico-chemical properties (Bioorganic and Medicinal Chemistry Letters (2011) 21 (5214-5218))

    Bioorganic and Medicinal Chemistry Letters

  2. Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 7, pp. 3268-3274

  3. Quinolone-3-diarylethers: A new class of antimalarial drug

    Science Translational Medicine, Vol. 5, Núm. 177

  4. Red blood cells derived from peripheral blood and bone marrow CD34+ human haematopoietic stem cells are permissive to Plasmodium parasites infection

    Memorias do Instituto Oswaldo Cruz, Vol. 108, Núm. 6, pp. 801-803